Published in Alcohol Clin Exp Res on November 01, 2010
Altered hepatic lipid metabolism in C57BL/6 mice fed alcohol: a targeted lipidomic and gene expression study. J Lipid Res (2011) 1.21
UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model. J Proteome Res (2011) 1.05
Dynamic phosphometabolomic profiling of human tissues and transgenic models by 18O-assisted ³¹P NMR and mass spectrometry. Physiol Genomics (2012) 0.94
Lipidomic changes in rat liver after long-term exposure to ethanol. Toxicol Appl Pharmacol (2011) 0.92
Dietary fat sources differentially modulate intestinal barrier and hepatic inflammation in alcohol-induced liver injury in rats. Am J Physiol Gastrointest Liver Physiol (2013) 0.88
Liver proteomics in progressive alcoholic steatosis. Toxicol Appl Pharmacol (2012) 0.85
Investigation of chronic alcohol consumption in rodents via ultra-high-performance liquid chromatography-mass spectrometry based metabolite profiling. J Chromatogr A (2012) 0.79
Hepatic lipid profiling of deer mice fed ethanol using ¹H and ³¹P NMR spectroscopy: a dose-dependent subchronic study. Toxicol Appl Pharmacol (2012) 0.77
Altered hepatic retinyl ester concentration and acyl composition in response to alcohol consumption. Biochim Biophys Acta (2013) 0.77
Alcoholic Steatosis in Different Strains of Rat: A Comparative Study. J Drug Alcohol Res (2015) 0.75
The hepatic lipidome: a gateway to understanding the pathogenesis of alcohol-induced fatty liver. Curr Mol Pharmacol (2015) 0.75
Structure, function and metabolism of hepatic and adipose tissue lipid droplets: implications in alcoholic liver disease. Curr Mol Pharmacol (2015) 0.75
Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol (2008) 13.77
Steatohepatitis: a tale of two "hits"? Gastroenterology (1998) 13.21
Molecular mediators of hepatic steatosis and liver injury. J Clin Invest (2004) 9.40
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc (2007) 5.92
Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res (2008) 3.96
The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem (1988) 2.69
Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem (2002) 2.61
Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology (2003) 2.40
Nonalcoholic steatohepatitis. Gastroenterology (2001) 2.12
Liquid diet technique of ethanol administration: 1989 update. Alcohol Alcohol (1989) 2.09
Regulation of phospholipid biosynthesis in isolated rat hepatocytes. Effect of different substrates. J Biol Chem (1975) 1.93
Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol (2004) 1.78
Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res (2008) 1.59
Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway. J Biol Chem (1999) 1.54
Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am J Physiol Gastrointest Liver Physiol (2000) 1.48
Role of dietary, adipose, and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver. J Clin Invest (1966) 1.44
Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. J Hepatol (2006) 1.39
1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. Nat Med (1999) 1.38
Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis. Toxicol Appl Pharmacol (2005) 1.31
Liver disease in alcohol abusers: clinical perspective. Alcohol (2002) 1.31
Physical studies of phospholipids. IV. High resolution nuclear magnetic resonance spectra of phospholipids and related substances. J Biol Chem (1966) 1.29
Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium. Hepatology (2006) 1.25
Diagnosing inborn errors of lipid metabolism with proton nuclear magnetic resonance spectroscopy. Clin Chem (2006) 1.20
Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice. Toxicol Appl Pharmacol (2007) 1.18
Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol (2004) 1.17
Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol (2005) 1.16
Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease. Toxicol Appl Pharmacol (2008) 1.14
Analysis of unsaturated C27 sterols by nuclear magnetic resonance spectroscopy. J Lipid Res (1996) 1.12
The enzymatic synthesis of fatty acid methyl esters by carboxyl group alkylation. J Biol Chem (1970) 1.11
Alcohol and lipid metabolism. J Gastroenterol Hepatol (2006) 1.11
Characterization of lipid composition in stimulated human lymphocytes by 1H-NMR. Biochim Biophys Acta (1990) 1.09
Mechanisms of alcohol-associated cancers: introduction and summary of the symposium. Alcohol (2005) 1.09
Kinetic analyses of liver phosphatidylcholine and phosphatidylethanolamine biosynthesis using (13)C NMR spectroscopy. Biochim Biophys Acta (2002) 1.08
Effects of prolonged ethanol feeding on methionine metabolism in rat liver. Biochem Cell Biol (1987) 1.07
Depot fat as source of increased liver triglycerides after ethanol. Biochem Biophys Res Commun (1960) 1.05
Ethanol oxidizing enzymes: roles in alcohol metabolism and alcoholic liver disease. Prog Liver Dis (1995) 1.05
Metabonomics: systems biology in pharmaceutical research and development. Curr Opin Mol Ther (2004) 1.05
HEMODYNAMIC AND METABOLIC EFFECTS OF CHRONIC ALCOHOLISM IN MAN. Am J Cardiol (1965) 1.04
Endogenous liver carcinogenesis in the rat. Pathol Int (1999) 1.02
Reduction in VLDL, but not HDL, in plasma of rats deficient in choline. Biochem Cell Biol (1990) 1.01
Ethanol exposure depletes hepatic pigment epithelium-derived factor, a novel lipid regulator. Gastroenterology (2008) 0.99
Toxicological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum. Toxicol Appl Pharmacol (2007) 0.98
The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury. Biochem Pharmacol (2007) 0.98
AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats. Alcohol Clin Exp Res (2005) 0.98
Overexpression of peroxiredoxin 6 does not prevent ethanol-mediated oxidative stress and may play a role in hepatic lipid accumulation. J Pharmacol Exp Ther (2009) 0.97
NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats. Toxicol Lett (2007) 0.96
Nonpolar lipid methylation. Biosynthesis of fatty acid methyl esters by rat lung membranes using S-adenosylmethionine. J Biol Chem (1981) 0.96
Metabolic basis of ethanol-induced hepatic and pancreatic injury in hepatic alcohol dehydrogenase deficient deer mice. Alcohol (2006) 0.96
1H NMR-based metabolomic analysis of liver, serum, and brain following ethanol administration in rats. Chem Res Toxicol (2007) 0.95
Alleviation of acute ethanol-induced liver injury and impaired metabolomics of S-containing substances by betaine supplementation. Biochem Biophys Res Commun (2008) 0.94
High resolution 31P NMR of extracted phospholipids. J Lipid Res (1988) 0.93
An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate. J Proteome Res (2006) 0.90
Role of medium-chain triglycerides in the alcohol-mediated cytochrome P450 2E1 induction of mitochondria. Alcohol Clin Exp Res (2007) 0.89
1H-NMR and 13C-NMR lipid profiles of human renal tissues. Biopolymers (2003) 0.86
Assessment of 31P-NMR analysis of phospholipid profiles for potential differential diagnosis of human cerebral tumors. NMR Biomed (2009) 0.84
The influence of pharmacogenetics on fatty liver disease in the wistar and kyoto rats: a combined transcriptomic and metabonomic study. J Proteome Res (2007) 0.83
Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes. Toxicol Appl Pharmacol (2009) 0.82
Determination of phospholipids in olive oil by 31P NMR spectroscopy. J Agric Food Chem (2008) 0.81
EFFECT OF ETHANOL ON ELECTROLYTE TRANSPORT AND ELECTROGENESIS IN ANIMAL TISSUES. J Cell Physiol (1965) 0.81
Ethanol and lipid metabolism. Am J Clin Nutr (1999) 0.81
Fatty acid ethyl and methyl ester synthases, and fatty acid anilide synthase in HepG2 and AR42J cells: interrelationships and inhibition by tri-o-tolyl phosphate. Toxicol Appl Pharmacol (1999) 0.80
Nuclear magnetic resonance spectroscopic analysis of homoallylic and bis homoallylic substituted methyl fatty ester derivatives. Lipids (1995) 0.80
Lipid metabolism in ethanol-treated rat pups and adults: effects of folic Acid. Alcohol Alcohol (2008) 0.80
Increased endobiotic fatty acid methyl esters following exposure to methanol. Fundam Appl Toxicol (1995) 0.79
Beneficial role of dietary folic acid on cholesterol and bile acid metabolism in ethanol-fed rats. J Stud Alcohol Drugs (2009) 0.79
Metabolomics in alcohol research and drug development. Alcohol Res Health (2008) 0.78
The effect of ethanol and diazepam on the fatty acid composition of plasma and liver phospholipids in the rat. Biol Pharm Bull (1995) 0.78
Comparison of methyltransferase activities of pair-fed rats given adequate or methyl-deficient diets. Carcinogenesis (1988) 0.78
1H NMR spectroscopic studies of lipid extracts from human fatty liver. Biochem Biophys Res Commun (1993) 0.77
Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol (2004) 3.43
Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res (2007) 2.77
Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cells. J Virol (2002) 1.97
Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury. Hepatology (2008) 1.94
Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase? Hepatology (2010) 1.75
Pathway signature and cellular differentiation in clear cell renal cell carcinoma. PLoS One (2010) 1.70
Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J Biol Chem (2008) 1.67
Disease- and cell-specific expression of GP73 in human liver disease. Am J Gastroenterol (2004) 1.65
Immunofluorescence assay and flow-cytometry selection of bead-bound aptamers. Nucleic Acids Res (2003) 1.41
Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1). Cancer Res (2007) 1.39
Survival strategy of obligately intracellular Ehrlichia chaffeensis: novel modulation of immune response and host cell cycles. Infect Immun (2004) 1.34
Combinatorial selection and binding of phosphorothioate aptamers targeting human NF-kappa B RelA(p65) and p50. Biochemistry (2002) 1.31
Stochastic regulation in early immune response. Biophys J (2005) 1.31
Limited success of HCV antiviral therapy in United States veterans. Am J Gastroenterol (2002) 1.27
The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One (2012) 1.27
Transcriptional profiling of mRNA expression in the mouse distal colon. Gastroenterology (2008) 1.19
Construction and selection of bead-bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing. Nucleic Acids Res (2002) 1.16
Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression. Oncogene (2003) 1.15
Suppressing Wnt signaling by the hedgehog pathway through sFRP-1. J Biol Chem (2006) 1.14
Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis. Hepatology (2005) 1.13
Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis. Genomics (2003) 1.13
Identification of differentially activated cell-signaling networks associated with pichinde virus pathogenesis by using systems kinomics. J Virol (2006) 1.12
Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection. Gastroenterology (2012) 1.09
Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line. Int J Cancer (2005) 1.08
Differential signaling networks induced by mild and lethal hemorrhagic fever virus infections. J Virol (2006) 1.07
TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain. Proc Natl Acad Sci U S A (2004) 1.07
Getting the right cells to the array: Gene expression microarray analysis of cell mixtures and sorted cells. Cytometry A (2004) 1.05
RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells. Mol Cancer Ther (2006) 1.03
Altered retinoic acid metabolism in diabetic mouse kidney identified by O isotopic labeling and 2D mass spectrometry. PLoS One (2010) 1.03
Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Oncogene (2003) 1.02
Protein adducts of malondialdehyde and 4-hydroxynonenal in livers of iron loaded rats: quantitation and localization. Toxicology (2002) 1.02
Synergistic interaction of hyperthermia and Gemcitabine in lung cancer. Cancer Biol Ther (2005) 1.00
NMR structure of the viral peptide linked to the genome (VPg) of poliovirus. Peptides (2006) 0.99
Cognitive enhancement with rosiglitazone links the hippocampal PPARγ and ERK MAPK signaling pathways. J Neurosci (2012) 0.97
Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine. Biochim Biophys Acta (2012) 0.97
Solution structure of a cis-opened (10R)-N6-deoxyadenosine adduct of (9S,10R)-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene in a DNA duplex. Biochemistry (2003) 0.97
Structure of hybrid backbone methylphosphonate DNA heteroduplexes: effect of R and S stereochemistry. Biochemistry (2002) 0.97
Development and characterization of a novel in vivo model of carcinoid syndrome. Clin Cancer Res (2009) 0.96
Functional genomic analysis reveals cross-talk between peroxisome proliferator-activated receptor gamma and calcium signaling in human colorectal cancer cells. J Biol Chem (2007) 0.96
Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44. Biochemistry (2010) 0.96
Metabolic basis of ethanol-induced cytotoxicity in recombinant HepG2 cells: role of nonoxidative metabolism. Toxicol Appl Pharmacol (2006) 0.96
Metabolic basis of ethanol-induced hepatic and pancreatic injury in hepatic alcohol dehydrogenase deficient deer mice. Alcohol (2006) 0.96
A rat model of smoke inhalation injury: influence of combustion smoke on gene expression in the brain. Toxicol Appl Pharmacol (2005) 0.96
Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses. Proc Natl Acad Sci U S A (2013) 0.95
Glutathione-S-transferase A4-4 modulates oxidative stress in endothelium: possible role in human atherosclerosis. Atherosclerosis (2004) 0.95
The course of CCl4 induced hepatotoxicity is altered in mGSTA4-4 null (-/-) mice. Toxicology (2005) 0.95
Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections. J Gen Virol (2007) 0.95
Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III. Virology (2010) 0.94
RSV-induced prostaglandin E2 production occurs via cPLA2 activation: role in viral replication. Virology (2005) 0.93
Malondialdehyde-protein adducts in the spleens of aniline-treated rats: immunochemical detection and localization. J Toxicol Environ Health A (2003) 0.93
X-aptamers: a bead-based selection method for random incorporation of druglike moieties onto next-generation aptamers for enhanced binding. Biochemistry (2012) 0.92
Lipidomic changes in rat liver after long-term exposure to ethanol. Toxicol Appl Pharmacol (2011) 0.92
Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 protein. Bioorg Med Chem Lett (2008) 0.92
CadA negatively regulates Escherichia coli O157:H7 adherence and intestinal colonization. Infect Immun (2008) 0.91
Base-pairing properties of the oxidized cytosine derivative, 5-hydroxy uracil. Biochem Biophys Res Commun (2007) 0.91
Separation of synthetic oligonucleotide dithioates from monothiophosphate impurities by anion-exchange chromatography on a mono-q column. Anal Biochem (2002) 0.91
Proteomics improves the prediction of burns mortality: results from regression spline modeling. Clin Transl Sci (2012) 0.90
Ethanol-induced cytotoxicity in rat pancreatic acinar AR42J cells: role of fatty acid ethyl esters. Alcohol Alcohol (2007) 0.90
Chronic exposure to trichloroethene causes early onset of SLE-like disease in female MRL +/+ mice. Toxicol Appl Pharmacol (2007) 0.90
Oxidative DNA damage and its repair in rat spleen following subchronic exposure to aniline. Toxicol Appl Pharmacol (2008) 0.89
Endothelial glutathione-S-transferase A4-4 protects against oxidative stress and modulates iNOS expression through NF-kappaB translocation. Toxicol Appl Pharmacol (2008) 0.89
Selection of thioaptamers for diagnostics and therapeutics. Ann N Y Acad Sci (2006) 0.89
Solution structure and design of dithiophosphate backbone aptamers targeting transcription factor NF-kappaB. Bioorg Chem (2002) 0.89
Down-regulation of uPAR and cathepsin B retards cofilin dephosphorylation. Int J Oncol (2006) 0.88
Analysis of the differential host cell nuclear proteome induced by attenuated and virulent hemorrhagic arenavirus infection. J Virol (2008) 0.88
Novel, structure-based mechanism for uridylylation of the genome-linked peptide (VPg) of picornaviruses. Proteins (2006) 0.88
Verapamil stereoisomers induce antiproliferative effects in vascular smooth muscle cells via autophagy. Toxicol Appl Pharmacol (2012) 0.88
Attenuated and lethal variants of Pichindé virus induce differential patterns of NF-kappaB activation suggesting a potential target for novel therapeutics. Viral Immunol (2009) 0.88
Solution structure, dynamics, and thermodynamics of the native state ensemble of the Sem-5 C-terminal SH3 domain. Biochemistry (2003) 0.87
Smoke/burn injury-induced respiratory failure elicits apoptosis in ovine lungs and cultured lung cells, ameliorated with arteriovenous CO2 removal. Chest (2004) 0.87
Nitrotyrosine formation in splenic toxicity of aniline. Toxicology (2003) 0.86
Compartmentalized, functional role of angiogenin during spotted fever group rickettsia-induced endothelial barrier dysfunction: evidence of possible mediation by host tRNA-derived small noncoding RNAs. BMC Infect Dis (2013) 0.86
Whole-body hyperthermia induces up-regulation of vascular endothelial growth factor accompanied by neovascularization in cardiac tissue. Life Sci (2006) 0.85
Liver proteomics in progressive alcoholic steatosis. Toxicol Appl Pharmacol (2012) 0.85
Autoimmune response in MRL+/+ mice following treatment with dichloroacetyl chloride or dichloroacetic anhydride. Toxicol Appl Pharmacol (2006) 0.83
Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells. Oncogene (2004) 0.83
Mediating delta-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell. Am J Physiol Heart Circ Physiol (2007) 0.83
Structure-based vaccines provide protection in a mouse model of ehrlichiosis. PLoS One (2011) 0.83
Cognitive enhancing treatment with a PPARγ agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice. J Neurosci (2014) 0.83
Identification of proteins bound to a thioaptamer probe on a proteomics array. Biochem Biophys Res Commun (2006) 0.83
1H NMR-based metabonomic investigation of tributyl phosphate exposure in rats. Toxicol Lett (2010) 0.82
Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells. J Med Virol (2010) 0.82
The use of DNA microarrays to assess clinical samples: the transition from bedside to bench to bedside. Recent Prog Horm Res (2003) 0.82
Up-regulation of heme oxygenase-1 in rat spleen after aniline exposure. Free Radic Biol Med (2009) 0.82
Pancreatic injury in hepatic alcohol dehydrogenase-deficient deer mice after subchronic exposure to ethanol. Toxicol Appl Pharmacol (2010) 0.82